Losing the baby weight, when it will not shift
The last stone after a baby is often the hardest. Broken sleep, changed hormones and no time to yourself all work against you. UK-licensed GLP-1 treatment, prescribed by a registered pharmacist, can help once you are ready.
Important: GLP-1 weight loss medicines are not suitable during pregnancy or while breastfeeding. If you are breastfeeding, treatment is not right for you yet. Your prescribing pharmacist will always check this first.
Why baby weight is so stubborn
Post-baby weight is not a lack of effort. Several things stack up at once, at the exact time you have least energy to fight them.
Broken sleep
Night feeds and disturbed sleep raise the hunger hormones the next day, and push you towards quick, high-sugar food for energy.
Shifted hormones
Hormones take time to settle after birth. For many women that means fat is held around the middle long after the baby arrives.
No time for you
Meals become whatever is quick, often the baby's leftovers. Structured eating and exercise are the first things to go.
Stress and comfort eating
The mental load is real. Eating to cope is common, and it makes the last stone the hardest to move.
Your body did something remarkable. Wanting to feel like yourself again is not vanity, and struggling to get there is not failure.
How GLP-1 treatment can help
GLP-1 medicines such as Mounjaro and Wegovy are prescription-only treatments that support weight loss in suitable people. They are not a quick fix and they are not right for everyone. They are not suitable during pregnancy or breastfeeding. Like all medicines they can cause side effects, so they are prescribed and supervised by a clinician who checks the treatment is safe and appropriate for you before you start.
The effect most mums describe is that the food noise quietens down. The constant grazing, the finishing of the little one's plate, the tired late-night snacking, all of it eases off. When hunger is no longer fighting you all day, sensible eating stops feeling like one more job.
In clinical trials at 72 weeks, Mounjaro produced an average 22.5% reduction in body weight and Wegovy an average of 20.7%. Individual results vary depending on your starting weight, your dose, your lifestyle and how long you stay on treatment.
Treatments
Suitability is decided by our prescribing pharmacist after a clinical assessment, and only when you are no longer pregnant or breastfeeding. Generally, GLP-1 treatment is considered for adults with a BMI over 30, or over 27 with a weight-related health condition.
Mounjaro
Tirzepatide
- Average 22.5% body weight loss at 72 weeks
- Dual-action GLP-1 and GIP receptor agonist
- Weekly injection
Wegovy
Semaglutide
- Average 20.7% body weight loss at 72 weeks
- GLP-1 receptor agonist
- Weekly injection
What helps alongside the medicine
With a baby in the house, simple and repeatable beats perfect. These four habits fit around real life.
Protein first
A protein-led breakfast steadies hunger for hours and protects the muscle that keeps your metabolism working.
Walk with the pram
Daily walks count. You do not need the gym. Movement you can do with the baby is movement you will actually keep up.
Prep the easy wins
A few ready options in the fridge stop the grazing on quick, sugary food when time and energy run out.
Stay supervised
Prescriptions are reviewed every 3 months, so your dose and progress are monitored and side effects managed early.
Postnatal weight loss: your questions
Want to read more about weight loss and GLP-1 medication?
Read our Weight Loss Health GuideFind out if treatment is right for you
Check your eligibility in under three minutes. A qualified prescriber reviews your answers personally. No GP appointment needed.